Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(13/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(13/week)
News
United States
(421/week)
Manufacturing
(319/week)
Technology
(320/week)
Energy
(213/week)
Other Manufacturing
(264/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Programmed cell death
Jun 21, 2020
Ascentage Pharma Enters Clinical Collaboration to Evaluate the Combination of Bcl-2 and BTK Inhibitors
Jun 17, 2020
Ascentage Pharma Announces First Patient Dosed in the Phase II Clinical Study of IAP Antagonist APG-1387 in Combination with Entecavir for the Treatment of Patients with Chronic Hepatitis B
May 31, 2020
(ASCO2020) Ascentage Pharma Presents Latest Clinical Data of Apoptosis Targeting Drug Candidates, Showing Promising Clinical Effects with Combination Therapies
May 15, 2020
Ascentage Pharma to Present Six Abstracts at 2020 AACR Annual Meeting
Apr 07, 2020
Ascentage Pharma Announces Approval for the Phase Ib/II Clinical Study of Bcl-2 Inhibitor APG-2575 for the Treatment of Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma in China
Mar 29, 2020
Ascentage Pharma Releases 2019 Annual Results, Reports Increased Investment in R&D and Advances in Global Clinical Development
Mar 25, 2020
Kanazawa University Research: Insights into the Diagnosis and Treatment of Brain Cancer in Children
Mar 23, 2020
Ascentage Pharma Announces First Patient Dosed in the Global Phase Ib/II Clinical Study of Bcl-2 Inhibitor APG-2575 in the United States
Mar 11, 2020
IDEAYA Biosciences and Cancer Research UK Announce Expanded Research Collaboration for PARG, a DDR-Based Synthetic Lethality Target, Evaluating DNA Replication Vulnerabilities
Mar 06, 2020
BioTheryX Appoints Professor Yinon Ben-Neriah, M.D., Ph.D., to its Scientific Advisory Board
Nov 13, 2019
PMV Pharma Secures $62 Million in Series C Financing To Develop Cancer Drugs Targeting p53
Sep 05, 2019
Theragnostics Signs Agreement with AstraZeneca
Aug 05, 2019
Aprea Therapeutics Appoints Scott Coiante as Chief Financial Officer
Jul 14, 2019
Ascentage Pharma announces first patient dosed in Phase I clinical trial of APG-2575 in China as the first China-made Bcl-2 Inhibitor
Jun 03, 2019
Ascentage Pharma presents new clinical data of apoptosis-targeted drug candidates APG-115 and APG-1387 at 2019 ASCO
May 07, 2019
New Gene Therapies Hold Out Promise for Patients
Mar 25, 2019
Ascentage Pharma Announces Nine Abstracts To Be Presented at the 2019 American Association for Cancer Research Annual Meeting
Mar 25, 2019
Aprea Therapeutics Appoints Dr. Eyal C. Attar as Chief Medical Officer
Feb 28, 2019
Theragnostics Ltd Expands Oncology Portfolio With Licensing of radioPARP Inhibitor
Jan 25, 2019
Global PARP Inhibitors in Oncology Research Report 2018: Background, Mechanism of Action, and Clinical Development of PARP Inhibitors
Page 1
››
Latest News
Mar 29, 2024
Universal Display Corporation to Deliver Keynote Address and Sponsor ICDT 2024
Mar 29, 2024
Cepton, Inc. Reports Fourth Quarter and Full Year 2023 Results
Mar 29, 2024
Ascent Industries Reports Fourth Quarter and Full Year 2023 Results
Mar 29, 2024
Surf Air Mobility Reports Financial Results for Fourth Quarter and Full Year Ended December 31, 2023
Mar 29, 2024
Planet Reports Financial Results for Fourth Quarter and Full Fiscal Year 2024
Mar 29, 2024
Fastenal Releases 2024 Environmental, Social, and Governance (ESG) Report
Mar 29, 2024
Danimer Scientific Announces Fourth Quarter and Full Year 2023 Results
Mar 29, 2024
CVD Equipment Corporation Reports Fourth Quarter and Fiscal Year 2023 Financial Results
View all News
Agenda
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
21
May
United Arab Emirates
ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR Abu Dhabi 2024, 21-23 May 2024, ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR ACCELERATING TRANSFORMATION IN THE NATIONAL SECURITY ECOSYSTEM ISNR Abu Dhabi is the region’s most trusted...
View All Events